Elutia Inc. (ELUT)
Last updated: 2026-10-22 07:40:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Elutia Inc. (ELUT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.83, with a market capitalization of $35.90M and a P/E ratio of 0.70. Over the past 52 weeks, its price has ranged from $0.50 to $1.39. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$35.90M | |
$0.80 | |
$5.24 | |
$0.50 | |
$0.81 | |
81.65K | |
179.94K | |
0.70 | |
$1.39 | |
$0.50 | |
-- | |
-- |
Elutia Inc. (ELUT) Latest Closing Stock Price
Elutia Inc. (ELUT) last closed at $0.81 as of 2026-10-21 20:02:00, unchanged from the previous close of $0.81.
During the latest regular trading session, ELUT traded between $0.50 and $5.24, with a volume of 81.65K shares. The closing price was near the lower end and near the middle of its 52-week range.
Elutia Inc. (ELUT) 7-Day Stock Price Change
Over the past seven days, Elutia Inc. (ELUT) moved from $0.77 to $0.83, representing a gain of 7.60% ($0.06).
The stock traded between $0.71 and $0.85 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 107.96 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
ELUT 52-Week Price Position
Position in Range: 37.5%
ELUT is currently trading at $0.83, placing it 37.5% of the way from its 52-week low of $0.50 to its 52-week high of $1.39. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Elutia Inc. (ELUT)?
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Elutia Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 26 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Elutia Inc. (ELUT) Stock on MEXC
Eligible investors can buy real shares of Elutia Inc. (ELUT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Elutia Inc. (ELUT) stock price today?
2.Is ELUT stock going up or down today?
3.What is ELUT pre-market price?
4.What is ELUT after-hours price?
5.Is ELUT stock trading now?
6.Where does ELUT sit relative to its 52-week high and low?
7.What sector is Elutia Inc. in?
8.What is Elutia Inc.'s market capitalization and where is it listed?
9.How is ELUT valued in terms of P/E ratio and EPS?
10.Does Elutia Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ELUT Stock Calculator
Estimate the value between ELUT shares and USD.
ELUT Shares to USD
1.00 ELUT shares = 0.832 USD
Calculations are estimates based on the latest available price and are for reference only.


